Heron Therapeutics Inc
NASDAQ:HRTX 12:51:45 PM EDT
| Market Cap (Intraday) | 1.61B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $17.15 |
| 50-Day MA | $17.20 |
| 200-Day MA | $16.94 |
Heron Therapeutics Inc Stock, NASDAQ:HRTX
4242 Campus Point Court, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.251.4400
Number of Employees: 223
Description
Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.